Exploring Perspectives on Palliative and Supportive Care, to Inform Recommendations to Help People Live Well With Inflammatory Arthritis Throughout the Disease Course (ENRICH)
Study explores palliative care needs for inflammatory arthritis patients.
Plain English Summary
Palliative and Supportive Care to Help People With Arthritis to Live Well (ENRICH) is a Not Applicable clinical trial sponsored by Dorothy House Hospice studying Inflammatory Arthritis, Palliative Care. This study tests how palliative and supportive care can help people with inflammatory arthritis live better throughout their illness. It is for adults diagnosed with inflammatory arthritis, such as rheumatoid arthritis, who want to improve their quality of life. Participation involves online interviews, surveys, and focus groups to share your experiences and views. There are no direct medical treatments tested; the focus is on understanding care needs and improving support services. The trial aims to enroll 120 participants.
Official Summary
Palliative Care (PC) focuses on maximising quality of life and care for patients and their families in the last 1000 days of life. Supportive Care (SC) is provided earlier in life for people with a long-term health condition. People living with inflammatory arthritis, (such as rheumatoid arthritis) can experience ongoing pain, stiffness, limitations in their joints, and intrusive fatigue. This impacts daily living activities and emotional well-being. People with inflammatory arthritis would value support to manage symptoms across the course of their disease. They would like PC healthcare professionals (HCPs) to understand their conditions better, so they can live well to the end of their lives. Aims: The investigators will explore the potential role of Palliative and Supportive Care (PSC) for people with inflammatory arthritis. The investigators will describe any unmet patient need. The investigators will develop clinical and research recommendations to help people with inflammatory arthritis live well over the course of their disease. Plan: The investigators research will be conducted in three studies: Study 1: The investigators will conduct 1:1 online interviews with people with inflammatory arthritis to understand how PSC is perceived by them, and what their views are on how PSC may support them to live well. Study 2: The investigators will send an online survey to Rheumatologists, Primary Care, Community and PC HCPs, to understand: * if and how they work together currently; * their views on the role of PSC supporting people with inflammatory arthritis to live well. Study 3: The investigators will conduct online focus groups with volunteers from Studies 1 and 2, representatives from relevant national charities/organisations, and people who commission health services. Together the group will discuss the research findings and agree: * what the gap in patient care is; * recommendations for future clinical practice and research; * the key areas of importanc
Who Can Participate
Here is what you need to know about eligibility for this trial. You can join if you are over 18 and have been diagnosed with rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, or axial spondyloarthritis. You must be able to communicate in English or have access to an interpreter. You can be receiving palliative care services or not. You cannot join if you have cognitive impairment that makes communication difficult. This trial is studying Inflammatory Arthritis, Palliative Care, so participants generally need a confirmed diagnosis. The trial is currently accepting new participants.
What They're Measuring
The primary outcome measures will help determine how well palliative and supportive care can improve the daily lives and well-being of individuals living with inflammatory arthritis. The specific primary outcome measures are: Primary outcomes (through to study completion, an average of one year). These endpoints are how researchers determine whether the treatment is effective and will form the basis of any future regulatory submissions.
About This Phase
This study does not have a traditional clinical phase designation. It may be an observational study that follows patients without intervening in their care, an expanded access or compassionate use program, or other non-interventional research. These studies contribute valuable data about disease progression, treatment patterns, and patient outcomes.
Why This Trial Matters
This trial matters because it aims to fill a gap in care by understanding how to better support people with inflammatory arthritis to live well, managing pain and fatigue throughout their disease. This research targets Inflammatory Arthritis, Palliative Care, where improved treatment options are needed.
Investor Insight
This observational study, sponsored by Dorothy House Hospice, seeks to inform recommendations for palliative care in inflammatory arthritis, potentially impacting a significant patient population and
Is This Trial Right for Me?
Ask your doctor if this study is a good fit for you and what your role would involve. Be prepared to share your experiences and opinions through online interviews, surveys, and focus groups. Participation will require access to Microsoft Teams or a phone for interviews and discussions. This trial is currently recruiting participants. The trial is being conducted at 1 site. Always discuss clinical trial participation with your healthcare provider before making any decisions. This information is for educational purposes only and is not medical advice.
AI-generated analysis for educational purposes only. This is not medical advice. Discuss clinical trial participation with your doctor. Data sourced from ClinicalTrials.gov.
Study Design
- Study Type: OBSERVATIONAL
- Enrollment: 120 participants
Interventions
- OTHER: NONE - observational study — N/A as observational study
Primary Outcomes
- Primary outcomes (through to study completion, an average of one year)
Full Eligibility Criteria
Inclusion Criteria: * Adults (\> 18 years) with a diagnosis of arthritis (Rheumatoid, Psoriatic or Juvenile Idiopathic) or Axial Spondyloarthritis * able to understand and communicate in verbal and written English (or via an interpreter nominated by the participant or provided via an agency by the research team) * in receipt, or not in receipt of Palliative Care services * access to Microsoft Teams or a telephone * consent to sharing preferred contact details Exclusion Criteria: * Cognitive impairment that impedes communication * non-English speaker (should an interpreter not be available).
Trial Locations
- Dorothy House Hospice, Bath, Wiltshire, United Kingdom
Frequently Asked Questions
What is clinical trial NCT07491939?
NCT07491939 is a Not Applicable OBSERVATIONAL study titled "Palliative and Supportive Care to Help People With Arthritis to Live Well (ENRICH)." It is currently recruiting and is sponsored by Dorothy House Hospice. The trial targets enrollment of 120 participants.
What conditions does NCT07491939 study?
This trial investigates treatments for Inflammatory Arthritis, Palliative Care. The primary condition under study is Inflammatory Arthritis.
What treatments are being tested in NCT07491939?
The interventions being studied include: NONE - observational study (OTHER). N/A as observational study
What does Not Applicable mean for NCT07491939?
This study does not have a defined clinical phase. It may be an observational study, expanded access program, or other non-interventional research.
What is the current status of NCT07491939?
This trial is currently "Recruiting." It started on 2026-02-19. The estimated completion date is 2027-04.
Who is sponsoring NCT07491939?
NCT07491939 is sponsored by Dorothy House Hospice. The sponsor is responsible for funding, designing, and overseeing the clinical trial.
How many people can participate in NCT07491939?
The trial aims to enroll 120 participants. The trial is currently recruiting and accepting new participants.
How is NCT07491939 designed?
This is a observational study.
What are the primary outcomes being measured in NCT07491939?
The primary outcome measures are: Primary outcomes (through to study completion, an average of one year). These are the main endpoints researchers use to determine whether the treatment is effective.
Where is NCT07491939 being conducted?
This trial is being conducted at 1 site, including Bath, Wiltshire (United Kingdom).
Where can I find official information about NCT07491939?
The official record for NCT07491939 is available on ClinicalTrials.gov at https://clinicaltrials.gov/study/NCT07491939. This government database provides the most up-to-date and detailed information about the trial.
What is NCT07491939 testing in simple terms?
This study tests how palliative and supportive care can help people with inflammatory arthritis live better throughout their illness. It is for adults diagnosed with inflammatory arthritis, such as rheumatoid arthritis, who want to improve their quality of life.
Why is this trial significant?
This trial matters because it aims to fill a gap in care by understanding how to better support people with inflammatory arthritis to live well, managing pain and fatigue throughout their disease.
What are the potential risks of participating in NCT07491939?
The main risk is the time and emotional effort required to share personal experiences. Potential side effects are minimal as this is an observational study and does not involve medical treatments. Privacy and confidentiality of your information will be maintained. As with any clinical trial, participants are closely monitored and can withdraw at any time.
Should I consider participating in NCT07491939?
Ask your doctor if this study is a good fit for you and what your role would involve. Be prepared to share your experiences and opinions through online interviews, surveys, and focus groups. Participation will require access to Microsoft Teams or a phone for interviews and discussions. Always discuss clinical trial participation with your healthcare provider to determine if it is appropriate for your specific situation.
What does NCT07491939 signal from an investment perspective?
This observational study, sponsored by Dorothy House Hospice, seeks to inform recommendations for palliative care in inflammatory arthritis, potentially impacting a significant patient population and This is a Not Applicable trial, which is in early development stages.
What happens if the treatment in this trial doesn't work?
Participation involves online interviews, surveys, and focus groups to share your experiences and views. Participants in clinical trials always have the right to withdraw and pursue alternative treatments. The study team will help transition patients to other available options.
Related Conditions
More Inflammatory Arthritis Trials
This analysis is AI-generated and does not constitute medical advice. Always consult your healthcare provider before making decisions about clinical trial participation.